Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BNTX BioNTech	$109.65 +1.3%	$102.74	$76.53 ▼ $131.49	$26.44B	1.29	942,387 shs	613,718 shs
GNRC Generac	$152.37 +1.2%	$127.72	$99.50 ▼ $195.94	$9.00B	1.72	864,550 shs	716,859 shs
HES Hess	$142.42 -0.8%	$135.88	$123.79 ▼ $161.69	$44.55B	0.62	1.81 million shs	696,543 shs
PFE Pfizer	$25.45 +0.5%	$23.72	$20.92 ▼ $31.54	$144.29B	0.58	41.63 million shs	27.10 million shs
TALO Talos Energy	$8.55 -2.7%	$8.29	$6.23 ▼ $12.71	$1.54B	0.71	2.17 million shs	978,736 shs
WB Weibo	$9.47 -0.3%	$9.12	$7.03 ▼ $12.40	$2.32B	0.11	1.62 million shs	383,941 shs

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BNTX BioNTech	0.00%	+2.74%	-1.35%	+24.53%	+37.30%
GNRC Generac	0.00%	+6.87%	+19.37%	+36.08%	+10.39%
HES Hess	0.00%	+2.41%	+6.61%	+6.37%	-4.60%
PFE Pfizer	0.00%	+5.16%	+8.65%	+10.68%	-8.04%
TALO Talos Energy	0.00%	-1.63%	+4.78%	+23.29%	-28.03%
WB Weibo	0.00%	-2.07%	0.00%	+10.12%	+13.82%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BNTX BioNTech	2.362 of 5 stars	4.4	2.0	0.0	0.0	1.2	0.8	0.0
GNRC Generac	4.106 of 5 stars	3.3	1.0	0.0	1.9	3.9	2.5	1.3
HES Hess	4.8438 of 5 stars	3.3	4.0	2.5	1.2	2.0	2.5	3.1
PFE Pfizer	4.9757 of 5 stars	3.2	3.0	4.2	4.5	2.8	1.7	3.1
TALO Talos Energy	3.9008 of 5 stars	3.4	3.0	0.0	1.8	2.8	1.7	0.6
WB Weibo	1.9254 of 5 stars	1.0	1.0	3.3	0.0	1.4	3.3	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BNTX BioNTech	2.83	Moderate Buy	$137.86	25.73% Upside
GNRC Generac	2.65	Moderate Buy	$169.17	11.02% Upside
HES Hess	2.55	Moderate Buy	$162.86	14.35% Upside
PFE Pfizer	2.45	Hold	$28.55	12.20% Upside
TALO Talos Energy	2.78	Moderate Buy	$14.22	66.34% Upside
WB Weibo	2.00	Hold	$9.75	2.96% Upside

Current Analyst Ratings Breakdown

Latest HES, WB, GNRC, BNTX, PFE, and TALO Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/2/2025	HES Hess	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$147.00 ➝ $153.00
6/26/2025	HES Hess	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$193.00 ➝ $184.00
6/25/2025	BNTX BioNTech	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$138.00
6/16/2025	BNTX BioNTech	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$145.00 ➝ $138.00
6/16/2025	TALO Talos Energy	Capital One Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$14.00
6/11/2025	HES Hess	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$163.00 ➝ $173.00
6/5/2025	BNTX BioNTech	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$134.00 ➝ $145.00
6/3/2025	BNTX BioNTech	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$151.00 ➝ $155.00
6/2/2025	BNTX BioNTech	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$112.00
5/29/2025	BNTX BioNTech	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy ➝ Neutral	$110.00
5/29/2025	PFE Pfizer	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold	$28.00 ➝ $25.00

(Data available from 7/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BNTX BioNTech	$2.98B	8.85	N/A	N/A	$87.61 per share	1.25
GNRC Generac	$4.30B	2.10	$10.31 per share	14.78	$41.98 per share	3.63
HES Hess	$13.02B	3.38	$17.56 per share	8.11	$38.96 per share	3.66
PFE Pfizer	$63.63B	2.27	$4.37 per share	5.82	$15.62 per share	1.63
TALO Talos Energy	$1.97B	0.77	$6.02 per share	1.42	$15.34 per share	0.56
WB Weibo	$1.75B	1.31	$1.91 per share	4.96	$14.57 per share	0.65

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BNTX BioNTech	-$719.92M	-$3.40	N/A	N/A	N/A	-27.37%	-3.94%	-3.41%	8/4/2025 (Estimated)
GNRC Generac	$325.26M	$5.74	26.55	17.06	1.37	7.68%	18.90%	9.00%	7/30/2025 (Estimated)
HES Hess	$2.77B	$7.23	19.70	12.38	N/A	17.65%	21.78%	9.72%	7/30/2025 (Estimated)
PFE Pfizer	$8.03B	$1.38	18.44	8.40	0.92	12.62%	20.33%	8.53%	8/5/2025 (Estimated)
TALO Talos Energy	-$76.39M	$0.15	57.00	N/A	N/A	1.27%	-0.24%	-0.10%	8/6/2025 (Estimated)
WB Weibo	$300.80M	$1.38	6.86	6.81	N/A	20.41%	12.29%	6.41%	8/20/2025 (Estimated)

Latest HES, WB, GNRC, BNTX, PFE, and TALO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/30/2025	Q2 2025	GNRC Generac	$1.35	N/A	N/A	N/A	$1.03 billion	N/A
7/30/2025	Q2 2025	HES Hess	$1.22	N/A	N/A	N/A	$2.69 billion	N/A
5/21/2025	Q1 2025	WB Weibo	$0.38	$0.45	+$0.07	$0.41	$394.21 million	$396.86 million
4/30/2025	Q1 2025	GNRC Generac	$0.99	$1.26	+$0.27	$0.73	$921.78 million	$942.12 million
4/30/2025	Q1 2025	HES Hess	$1.95	$1.81	-$0.14	$1.39	$2.95 billion	$2.92 billion
4/29/2025	Q1 2025	PFE Pfizer	$0.67	$0.92	+$0.25	$0.52	$14.43 billion	$13.72 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BNTX BioNTech	N/A	N/A	N/A	N/A	N/A
GNRC Generac	N/A	N/A	N/A	N/A	N/A
HES Hess	$2.00	1.40%	N/A	27.66%	3 Years
PFE Pfizer	$1.72	6.76%	N/A	124.64%	16 Years
TALO Talos Energy	N/A	N/A	N/A	N/A	N/A
WB Weibo	$0.80	8.45%	N/A	57.97%	N/A

Latest HES, WB, GNRC, BNTX, PFE, and TALO Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/25/2025	PFE Pfizer	quarterly	$0.43	7.08%	7/25/2025	7/25/2025	9/2/2025
5/14/2025	HES Hess	quarterly	$0.50	1.49%	6/16/2025	6/16/2025	6/30/2025
4/23/2025	PFE Pfizer	quarterly	$0.43	7.69%	5/9/2025	5/9/2025	6/13/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BNTX BioNTech	0.01	10.18	10.02
GNRC Generac	0.48	1.97	0.89
HES Hess	0.71	1.08	0.91
PFE Pfizer	0.64	1.26	0.96
TALO Talos Energy	0.45	1.05	1.05
WB Weibo	0.53	2.72	2.72

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BNTX BioNTech	15.52%
GNRC Generac	84.04%
HES Hess	88.51%
PFE Pfizer	68.36%
TALO Talos Energy	89.35%
WB Weibo	68.77%

Insider Ownership

Company	Insider Ownership
BNTX BioNTech	19.20%
GNRC Generac	2.70%
HES Hess	9.10%
PFE Pfizer	0.06%
TALO Talos Energy	0.36%
WB Weibo	41.30%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BNTX BioNTech	6,772	240.39 million	194.24 million	Optionable
GNRC Generac	9,239	59.08 million	57.49 million	Optionable
HES Hess	1,797	309.31 million	281.16 million	Optionable
PFE Pfizer	81,000	5.69 billion	5.68 billion	Optionable
TALO Talos Energy	440	177.15 million	176.51 million	Optionable
WB Weibo	4,982	242.61 million	142.41 million	Optionable

HES, WB, GNRC, BNTX, PFE, and TALO Headlines

Recent News About These Companies

WB - Weibo Corp ADR Price vs Fair Value - Morningstar

July 2 at 8:46 PM | morningstar.comM

WB - Weibo Corp ADR Financials - Morningstar

July 2 at 8:46 PM | morningstar.comM

Weibo Corporation (NASDAQ:WB) Shares Acquired by Krane Funds Advisors LLC

July 2 at 9:09 AM | marketbeat.com

Head-To-Head Survey: Weibo (NASDAQ:WB) and Beyond Commerce (OTCMKTS:BYOC)

July 1, 2025 | americanbankingnews.com

Weibo Corporation's (NASDAQ:WB) top owners are private companies with 36% stake, while 28% is held by private equity firms

June 19, 2025 | finance.yahoo.com

Weibo (NASDAQ:WB) Stock Crosses Above 50 Day Moving Average - Time to Sell?

June 17, 2025 | marketbeat.com

Weibo: AI Bet Faces The Test Of Relevance In A Shifting Social Media Landscape

June 5, 2025 | seekingalpha.com

Weibo Beats Q1 Estimates But Benchmark Sees Growth Concerns

May 27, 2025 | insidermonkey.com

CN CAC Rectifies Online Financial Info Chaos, Closes Accounts & Websites w/ Illegal Stock Recommendations

May 26, 2025 | aastocks.comA

Weibo (WB) Receives a Hold from Benchmark Co.

May 25, 2025 | theglobeandmail.com

Weibo Corp’s Earnings Call Highlights Stable Growth Amid Challenges

May 22, 2025 | tipranks.com

Investors in Weibo (NASDAQ:WB) have unfortunately lost 63% over the last five years

May 22, 2025 | finance.yahoo.com

Weibo Corporation (NASDAQ:WB) Q1 2025 Earnings Call Transcript

May 22, 2025 | msn.com

Weibo Corp (WB) Q1 2025 Earnings Call Highlights: Steady Revenue and User Growth Amidst ...

May 22, 2025 | gurufocus.com

Weibo’s Q1 2025: Stable Revenues and AI Progress

May 21, 2025 | tipranks.com

Weibo Corporation: Weibo Announces First Quarter 2025 Unaudited Financial Results

May 21, 2025 | finanznachrichten.de

China's Twitter-Like Platform Weibo Keeps User Engagement High, Credits AI-Recommendation Engine

May 21, 2025 | benzinga.com

Weibo Corporation (WB) Q1 2025 Earnings Call Transcript

May 21, 2025 | seekingalpha.com

Weibo Reports Q1 2025 Financial Results with Steady Growth

May 21, 2025 | tipranks.com

State Republicans push SEC to scrutinize U.S.-listed Chinese firms over investor risks - report

May 20, 2025 | msn.com

Earnings Preview For Weibo

May 20, 2025 | benzinga.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

3 Stocks Getting Rare Double Upgrades From Analysts
By Chris Markoch | June 6, 2025
View 3 Stocks Getting Rare Double Upgrades From Analysts
Don’t Miss These 2 Small Quantum Stocks Poised to Pop
By Gabriel Osorio-Mazilli | June 24, 2025
View Don’t Miss These 2 Small Quantum Stocks Poised to Pop
Breakout Momentum Plays You May Not Know About
By Nathan Reiff | June 6, 2025
View Breakout Momentum Plays You May Not Know About
Why Goldman Sachs Suddenly Boosted These 3 Trucking Stocks
By Gabriel Osorio-Mazilli | June 9, 2025
View Why Goldman Sachs Suddenly Boosted These 3 Trucking Stocks
As Oil Prices Rebound, These Stocks Could Fuel the Next Rally
By Sarah Horvath | June 9, 2025
View As Oil Prices Rebound, These Stocks Could Fuel the Next Rally

HES, WB, GNRC, BNTX, PFE, and TALO Company Descriptions

BioNTech NASDAQ:BNTX

$109.64 +1.39 (+1.28%)

Closing price 07/3/2025 03:53 PM Eastern

Extended Trading

$109.64 0.00 (0.00%)

As of 07/3/2025 04:53 PM Eastern

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV 16+ head and neck cancers; BNT114 to treat triple negative breast cancer; BNT115, which is in Phase I clinical trial in ovarian cancer; and BNT116, which is in Phase I clinical trial for non-small cell lung cancer. It develops BNT122, which is in Phase II clinical trial for first-line melanoma and in Phase I clinical trial to treat multiple solid tumors; BNT131 that is in Phase I clinical trial for multiple solid tumors; BNT141 and BNT142 that are in Phase I clinical trial to treat multiple solid tumors; BNT151, BNT152, and BNT153 to treat solid tumors; BNT211 to treat multiple solid tumors, and BNT221 for pancreatic and other cancers; BNT311 which are in Phase II clinical trial to treat metastatic non-small cell lung cancer and Phase I/II clinical trial to treat multiple solid tumors; and BNT312, which is in Phase 2 clinical trial to treat multiple solid tumors, as well as ONC-392, which is in Phase III clinical trial to treat ovarian cancer and Phase I/II clinical trial to treat multiple solid tumors. It develops BNT321, an IgG1 monoclonal antibody in Phase I clinical trial for pancreatic cancer; BNT411, a small molecule immunomodulator product candidate in Phase I clinical trial for solid tumors; BNT322, which is in Phase I/Ib clinical trial for multiple solid tumors; and prophylactic vaccine for shingles, malaria, tuberculosis, HSV-2, and other infectious diseases. It has collaborations with Genentech, Inc.; Sanofi S.A.; Genmab A/S; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd; and Ryvu Therapeutics S.A. BioNTech SE was incorporated in 2008 and is based in Mainz, Germany.

Generac NYSE:GNRC

$152.37 +1.75 (+1.16%)

Closing price 07/3/2025 03:30 PM Eastern

Extended Trading

$152.08 -0.28 (-0.19%)

As of 07/3/2025 04:45 PM Eastern

Generac Holdings Inc. designs, manufactures, and distributes various energy technology products and solution worldwide. The company offers residential automatic standby generators, automatic transfer switch, air-cooled engine residential standby generators, and liquid-cooled engine generators; Mobile Link, a remote monitoring system for home standby generators; residential storage solution, which consists of a system of batteries, an inverter, photovoltaic optimizers, power electronic controls, and other components; smart home solutions, such as smart thermostats and a suite of home monitoring products. It also provides smart home energy management devices and sensors for heating and cooling system; smart doorbell cameras; and portable and inverter generators; multiple portable battery solutions; manual transfer switches; outdoor power equipment, including trimmers, field and brush mowers, log splitters, stump grinders, chipper shredders, lawn and leaf vacuums, and pressure washers and water pumps; and battery-powered turf care products. In addition, the company offers commercial and industrial products comprising cleaner-burning natural gas fueled generators; light-commercial standby generators and related transfer switches; stationary generators; single-engine industrial generators; industrial standby generators; industrial transfer switches; light towers, mobile generators, commercial mobile pumps, heaters, dust-suppression equipment, and mobile energy storage systems; stationary energy storage system and related inverter products; and aftermarket service parts and product accessories. The company distributes its products through independent residential dealers, industrial distributors and dealers, national and regional retailers, e-commerce partners, electrical/HVAC/solar wholesalers, solar installers, catalogs, equipment rental companies, and other equipment distributors; and directly to end users. The company was founded in 1959 and is headquartered in Waukesha, Wisconsin.

Hess NYSE:HES

$142.42 -1.11 (-0.77%)

Closing price 07/3/2025 03:48 PM Eastern

Extended Trading

$141.83 -0.58 (-0.41%)

As of 07/3/2025 04:23 PM Eastern

Hess Corporation, an exploration and production company, explores, develops, produces, purchases, transports, and sells crude oil, natural gas liquids (NGLs), and natural gas. The company operates in two segments, Exploration and Production, and Midstream. It conducts production operations primarily in the United States, Guyana, the Malaysia/Thailand Joint Development Area, and Malaysia; and exploration activities principally offshore Guyana, the U.S. Gulf of Mexico, and offshore Suriname and Canada. The company is also involved in gathering, compressing, and processing natural gas; fractionating NGLs; gathering, terminaling, loading, and transporting crude oil and NGL through rail car; and storing and terminaling propane, as well as providing water handling services primarily in the Bakken Shale plays in the Williston Basin area of North Dakota. The company was incorporated in 1920 and is headquartered in New York, New York.

Pfizer NYSE:PFE

$25.44 +0.13 (+0.49%)

Closing price 07/3/2025 03:59 PM Eastern

Extended Trading

$25.42 -0.03 (-0.11%)

As of 07/3/2025 05:00 PM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Talos Energy NYSE:TALO

$8.55 -0.24 (-2.73%)

Closing price 07/3/2025 03:36 PM Eastern

Extended Trading

$8.55 0.00 (0.00%)

As of 07/3/2025 04:20 PM Eastern

Talos Energy Inc., through its subsidiaries, engages in the exploration and production of oil, natural gas, and natural gas liquids in the United States and Mexico. It also engages in the development of carbon capture and sequestration. Talos Energy Inc. was founded in 2011 and is headquartered in Houston, Texas.

Weibo NASDAQ:WB

$9.47 -0.03 (-0.32%)

Closing price 07/3/2025 03:06 PM Eastern

Extended Trading

$9.47 0.00 (0.00%)

As of 07/3/2025 04:24 PM Eastern

Weibo Corporation, through its subsidiaries, operates as a social media platform for people to create, discover, and distribute content in the People's Republic of China. It operates in two segments, Advertising and Marketing Services; and Value-Added Services. The company offers discovery products to help users discover content on its platform; self-expression products that enable its users to express themselves on its platform; and social products to promote social interaction between users on its platform. It also provides advertising and marketing solutions, such as social display advertisements; and promoted marketing offerings, such as Fans Headline and Weibo Express promoted feeds, as well as promoted trends and search products that appear alongside user's trends discovery and search behaviors. In addition, the company offers products, such as trends, search, video/live streaming, and editing tools; content customization, copyright contents pooling, and user interaction development; and search list recommendation, trends list recommendation, and Weibo app opening advertisements. Further, it provides back-end management, traffic support, and product services for better displaying and promotion of its account and content; open application platform for other app developers that allows users to log into third-party applications with their Weibo account for sharing third-party content on its platform; and Weibo Wallet, a product that enables platform partners to conduct interest generation activities on Weibo, such as handing out red envelops and coupons. The company was formerly known as T.CN Corporation and changed its name to Weibo Corporation in 2012. The company was founded in 2009 and is headquartered in Beijing, the People's Republic of China.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare MarketRank™

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest HES, WB, GNRC, BNTX, PFE, and TALO Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest HES, WB, GNRC, BNTX, PFE, and TALO Earnings

Compare Dividends

Latest HES, WB, GNRC, BNTX, PFE, and TALO Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

HES, WB, GNRC, BNTX, PFE, and TALO Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

HES, WB, GNRC, BNTX, PFE, and TALO Company Descriptions

BioNTech NASDAQ:BNTX

Generac NYSE:GNRC

Hess NYSE:HES

Pfizer NYSE:PFE

Talos Energy NYSE:TALO

Weibo NASDAQ:WB

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools